40
Views
1
CrossRef citations to date
0
Altmetric
Original Papers

A Six-Month Study of Growth and Energy Expenditure in Children with Cystic Fibrosis Taking a Pulmonary Inhalation Medication (rhDNase)

, PhD, RD, , MA, , MD, , PhD, , MSN, CRNP, , MD & , MD show all
Pages 330-338 | Received 01 Aug 1998, Accepted 01 Mar 1999, Published online: 07 Jun 2013

REFERENCES

  • FitzSimmons SC: The changing epidemiology of cystic fibrosis. J Pediatr 122: 1–9, 1993.
  • Collins FS: Cystic Fibrosis: molecular biology and therapeutic implications. Science 256: 774–779, 1992.
  • Robinson C, Scanlin TF: Cystic Fibrosis. In Fishman AP (ed) “Pulmonary Diseases and Disorders,” 3rd ed, Volume 1. Colombus, OH: McGraw-Hill, pp 803–824, 1997.
  • FitzSimmons SC: “Cystic Fibrosis Patient Registry Annual Data Report, 1997.” Bethesda, MD: Cystic Fibrosis Foundation, 1998.
  • Kraemer R, Rudeberg A, Hadorn B, Rossi E: Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 67: 33–37, 1978.
  • Tomezsko JL, Stallings VA, Kawchak DA, Goin JE, Diamond G, Scanlin TF: Energy expenditure and genotype of children with cystic fibrosis. Pediatr Res 35: 451–460, 1994.
  • Shephard R, Vasques-Velasquez L, Prentice A, Holt T, Coward W, Lucas A: Increased energy expenditure in young children with cystic fibrosis. Lancet 1: 1300–1303, 1988.
  • Fried M, Durie P, Tsui LC, Corey M, Levison H, Pencharz P: The cystic fibrosis gene and resting energy expenditure. J Pediatr 119: 913–916, 1991.
  • Bowler IM, Green JH, Wolfe SP, Littlewood JM: Resting energy expenditure and substrate oxidation rates in cystic fibrosis. Arch Dis Child 68: 754–759, 1993.
  • Hirsch JA, Zhang W, Rudnick M, Cerny F, Cropp G: Resting energy oxygen consumption and ventilation in cystic fibrosis. Pediatr Pulmonol 6: 19–26, 1989.
  • Zemel BS, Kawchak DA, Cnaan A, Zhao H, Scanlin TF, Stallings VA: Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function and genotype in children with cystic fibrosis. Pediatric Res 40: 578–586, 1996.
  • Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL: Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 87: 9188–9192, 1990.
  • Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV: Efficacy and safety of short term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 148: 145–151, 1993.
  • Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME: Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 331: 637–642, 1994.
  • Ramsey BW: Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 335: 179–188, 1996.
  • Amin N, Dozor AJ: Effects of administration of aerosolized recombinant human deoxyribonuclease on resting energy expenditure in patients with cystic fibrosis. Pediatr Pulmonol 18: 150–154, 1994.
  • Geller D, Eigen H, Fiel S, Lamarre A, Konstan M, Johnson C for the Pulmozyme Nebulizer Study Group: Aerolized dornase alfa in cystic fibrosis: smaller particle size may improve outcome in patients with mild obstructive lung disease. Israel J Med Sci 32: S35, 1996.
  • Tomezsko J, Stallings V, Scanlin T: Dietary intake of healthy children with cystic fibrosis compared to normal children. Pediatrics 90: 547–553, 1992.
  • Cameron N: The methods of auxological anthropometry. In Falkner F, Tanner JM (eds): “Human Growth: A Comprehensive Treatise,” 2nd ed, Vol 2. New York: Plenum Press, pp 3–46, 1986.
  • Cronk CE, Stallings VA, Spender QW, Ross JL: Measurement of short-term growth with a new knee height measuring device. Am J Hum Biol 1: 421–428, 1989.
  • Hamill P, Drizd T, Johnson C, Reed R, Roche A, Moore W: Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 32: 607–627, 1979.
  • Cole TJ: The use and construction of anthropometric growth reference standards. Nutrition Research Reviews 6: 19–50, 1993.
  • Frisancho AR: “Anthropometric Standards for the Assessment of Growth and Nutritional Status.” Ann Arbor: University of Michigan Press, 1990.
  • Stallings VA, Cronk CE: Clinical use of the knee height measuring device to detect growth deficiency. Am J Hum Biol 5: 623–632, 1993
  • Baumgartner RN, Roche AF, Himes JH: Incremental growth tables: supplementary to previously published charts. Am J Clin Nutr 43: 711–712, 1986.
  • Brook G: Determination of body composition of children from skinfold measurements. Arch Dis Child 46: 182–184, 1971.
  • Durnin J, Rahaman M: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Brit J Nutr 21: 681–689, 1967.
  • Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bember DA: Skinfold equations for estimation of body fatness in children and youth. Hum Biol 60: 709–723, 1988.
  • Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H: “Assessment of skeletal maturity and prediction of adult height (TW2 Method).” London: Academic Press, 1975.
  • Morris NN, Udry JR. Validation of self administered instrument to assess stage of adolescent development. J Youth and Adol 9: 271–280, 1980.
  • Tanner JM. “Growth at Adolescence,” 2nd ed. Oxford: Blackwell Scientific, 1962.
  • Kawchak DA, Zhao H, Scanlin TF, Tomezsko JL, Cnaan A, Stallings VA: Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis. J Pediatr 129: 119–129, 1996.
  • National Research Council: Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press, 1989.
  • Ramsey BW, Farrell PM, Pencharz P and the Consensus Committee: Nutrition assessment and management in cystic fibrosis: consensus report. Am J Clin Nutr 55: 108–115, 1992.
  • Weir J: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1–9, 1949.
  • FAO/WHO/UNU Expert Consultation: “Energy and Protein Requirements.” Geneva: World Health Organization, 71–112, 1985.
  • Morris A, Kanner R, Crapo R, Gardner R: “Clinical Pulmonary Function Testing,” 2nd ed. Salt Lake City: Intermountain Thoracic Society, pp. 1–240, 1984.
  • Zapletal A, Samanek M, Paul T: Lung function in children and adolescents: methods, reference values. In Herzog H (ed): “Progress in Respiration Research.” Basel: Karger, pp. 1–220, 1987.
  • Brasfield D, Hicks G, Soong S, Tiller RE: The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 63: 24–29, 1979.
  • Poehlman ET, Toth MJ: Mathematical ratios lead to spurious conclusions regarding age- and sex-related differences in resting metabolic rate. Amer J Clin Nutr 61: 482–485, 1995.
  • Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, Shen G, Walker S, Farrell PM: Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 132: 478–485, 1998.
  • Bandini LG, Cyr H, Must A, Dietz WH: Validity of reported energy intake in pre-adolescent girls. Am J Clin Nutr 65(Suppl) 1138S–1141S, 1997.
  • Rockett HRH, Colditz GA: Assessing diets of children and adolescents. Am J Clin Nutr 65(Suppl) 1116S–1122S, 1997.
  • Schoeller DA: Measurement of energy expenditure in free living humans using doubly labeled water. J Nutr 118: 1278–1289, 1988.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.